[go: up one dir, main page]

DE69310353D1 - 2,3,4,5-tetrahydro-1h-3-benzazepine und ihre pharmazeutisch verträglichen säureadditionssalze - Google Patents

2,3,4,5-tetrahydro-1h-3-benzazepine und ihre pharmazeutisch verträglichen säureadditionssalze

Info

Publication number
DE69310353D1
DE69310353D1 DE69310353T DE69310353T DE69310353D1 DE 69310353 D1 DE69310353 D1 DE 69310353D1 DE 69310353 T DE69310353 T DE 69310353T DE 69310353 T DE69310353 T DE 69310353T DE 69310353 D1 DE69310353 D1 DE 69310353D1
Authority
DE
Germany
Prior art keywords
tetrahydro
benzazepine
acid addition
addition salts
pharmaceutically compatible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69310353T
Other languages
English (en)
Other versions
DE69310353T2 (de
Inventor
Christian Foged
Rolf Hohlweg
Erik Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paion UK Ltd
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of DE69310353D1 publication Critical patent/DE69310353D1/de
Application granted granted Critical
Publication of DE69310353T2 publication Critical patent/DE69310353T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69310353T 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1h-3-benzazepine und ihre pharmazeutisch verträglichen säureadditionssalze Expired - Fee Related DE69310353T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK92233A DK23392D0 (da) 1992-02-24 1992-02-24 Heterocykliske forbindelser, deres anvendelse og fremstilling
PCT/DK1993/000041 WO1993017012A1 (en) 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof

Publications (2)

Publication Number Publication Date
DE69310353D1 true DE69310353D1 (de) 1997-06-05
DE69310353T2 DE69310353T2 (de) 1997-10-02

Family

ID=8091236

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69310353T Expired - Fee Related DE69310353T2 (de) 1992-02-24 1993-02-05 2,3,4,5-tetrahydro-1h-3-benzazepine und ihre pharmazeutisch verträglichen säureadditionssalze

Country Status (23)

Country Link
EP (1) EP0628039B1 (de)
JP (1) JPH07504172A (de)
KR (1) KR100255739B1 (de)
AT (1) ATE152450T1 (de)
AU (1) AU667878B2 (de)
BG (1) BG62208B1 (de)
CA (1) CA2130678C (de)
CZ (1) CZ288626B6 (de)
DE (1) DE69310353T2 (de)
DK (2) DK23392D0 (de)
ES (1) ES2102019T3 (de)
FI (1) FI113770B (de)
GR (1) GR3023896T3 (de)
HU (1) HU221314B1 (de)
IL (1) IL104657A (de)
NO (1) NO310193B1 (de)
NZ (1) NZ249465A (de)
RO (1) RO116088B1 (de)
RU (1) RU2114839C1 (de)
SK (1) SK281390B6 (de)
UA (1) UA34451C2 (de)
WO (1) WO1993017012A1 (de)
ZA (1) ZA931099B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1945495A (en) * 1994-03-16 1995-10-03 Novo Nordisk A/S Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds
HUP9900746A3 (en) * 1995-09-15 1999-11-29 Cenes Ltd Histon Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds, process for their preparation and pharmaceutical compositions containing the same
GB0130576D0 (en) * 2001-12-20 2002-02-06 Cenes Ltd Dopamine D1 receptor agonist pro-drug compounds & derivatives
ES2401319T3 (es) * 2002-12-20 2013-04-18 Glaxo Group Limited Nuevo derivado de benzazepina
EP3842420B1 (de) 2012-10-25 2022-12-07 Tetra Discovery Partners LLC Heteroaryl-inhibitoren von pde4
US20150086480A1 (en) * 2013-09-26 2015-03-26 Tetra Discovery Partners, LLC Heteroaryl inhibitors of pde4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
DK325188D0 (da) * 1988-06-15 1988-06-15 Novo Industri As Hidtil ukendte benzazepinderivater
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater

Also Published As

Publication number Publication date
GR3023896T3 (en) 1997-09-30
ZA931099B (en) 1994-08-17
ATE152450T1 (de) 1997-05-15
RU2114839C1 (ru) 1998-07-10
NO310193B1 (no) 2001-06-05
DK23392D0 (da) 1992-02-24
BG98993A (bg) 1995-05-31
NO943123L (no) 1994-08-24
CA2130678A1 (en) 1993-08-25
CA2130678C (en) 2004-04-20
IL104657A0 (en) 1993-06-10
HUT71127A (en) 1995-11-28
RU94040719A (ru) 1996-07-10
KR100255739B1 (ko) 2000-05-01
IL104657A (en) 1999-11-30
AU3626593A (en) 1993-09-13
FI113770B (fi) 2004-06-15
DE69310353T2 (de) 1997-10-02
JPH07504172A (ja) 1995-05-11
CZ198894A3 (en) 1995-10-18
ES2102019T3 (es) 1997-07-16
NZ249465A (en) 1996-02-27
KR950700286A (ko) 1995-01-16
RO116088B1 (ro) 2000-10-30
EP0628039A1 (de) 1994-12-14
NO943123D0 (no) 1994-08-24
WO1993017012A1 (en) 1993-09-02
SK281390B6 (sk) 2001-03-12
FI943875L (fi) 1994-08-23
EP0628039B1 (de) 1997-05-02
AU667878B2 (en) 1996-04-18
FI943875A0 (fi) 1994-08-23
DK0628039T3 (da) 1997-12-08
HU9402434D0 (en) 1994-10-28
CZ288626B6 (cs) 2001-08-15
UA34451C2 (uk) 2001-03-15
SK100094A3 (en) 1995-04-12
BG62208B1 (bg) 1999-05-31
HU221314B1 (en) 2002-09-28

Similar Documents

Publication Publication Date Title
FI941378A0 (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
DE69232334D1 (de) Substituierte 3-aminochinuclidine
PH25571A (en) Alpha'-alkyl-4-amino-3-quinolinemethanols, 1-(4-aralkylamino-3-quinolinyl) alaknones, their use as medicaments
ATE206708T1 (de) Benzimidazolonderivate mit zentraler dopaminerger aktivität
FI970469A0 (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
DE69310353D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepine und ihre pharmazeutisch verträglichen säureadditionssalze
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
FI865220A0 (fi) Foerfarande foer framstaellning av sulfinyl- och sulfonylsubstituerade 3-benzazepiner.
ATE89553T1 (de) Hydroxy-1,2,3,4-tetrahydroaminoacridine, verfahren fuer ihre herstellung und ihre verwendung als arzneimittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CENES LTD., CAMBRIDGE, GB

8339 Ceased/non-payment of the annual fee